WWW.NATURE.COM
Targeting G1S-checkpoint-compromised cancers with cyclin A/B RxL inhibitors
Nature, Published online: 20 August 2025; doi:10.1038/s41586-025-09433-wDual cyclin A/B RxL inhibitors selectively kill small cell lung cancer cells and other cancer cells with high E2F activity.
0 Comentários 0 Compartilhamentos 42 Visualizações 0 Anterior